Literature DB >> 14500470

Up-regulation of interleukin-8 by novel small cytoplasmic molecules of nontypeable Haemophilus influenzae via p38 and extracellular signal-regulated kinase pathways.

Beinan Wang1, P Patrick Cleary, Haidong Xu, Jian-Dong Li.   

Abstract

Nontypeable Haemophilus influenzae (NTHI) is an important etiological agent of otitis media (OM) and of exacerbated chronic obstructive pulmonary diseases (COPD). Inflammation is a hallmark of both diseases. Interleukin-8 (IL-8), one of the important inflammatory mediators, is induced by NTHI and may play a significant role in the pathogenesis of these diseases. Our studies demonstrated that a soluble cytoplasmic fraction (SCF) from NTHI induced much greater IL-8 expression by human epithelial cells than did NTHI lipooligosaccharides and envelope proteins. The IL-8-inducing activity was associated with molecules of < or =3 kDa from SCF and was peptidase and lipase sensitive, suggesting that small lipopeptides are responsible for the strong IL-8 induction. Moreover, multiple intracellular signaling pathways were activated in response to cytoplasmic molecules. The results indicated that the p38 mitogen-activated protein kinase (MAPK) and Src-dependent Raf-1-Mek1/2-extracellular signal-regulated kinase mitogen-activated protein kinase (ERK MAPK) pathways are required for NTHI-induced IL-8 production. In contrast, the phosphatidylinositol 3-kinase (PI3K)-Akt pathway did not affect IL-8 expression, although this pathway was concomitantly activated upon exposure to NTHI SCF. The PI3K-Akt pathway was also directly activated by IL-8 and significantly inhibited by an antagonist of IL-8 receptors during NTHI stimulation. These results indicated that the PI3K-Akt pathway is activated in response to IL-8 that is induced by NTHI and may lead to other important epithelial cell responses. This work provides insight into essential molecular and cellular events that may impact on the pathogenesis of OM and COPD and identifies rational targets for anti-inflammatory intervention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500470      PMCID: PMC201079          DOI: 10.1128/IAI.71.10.5523-5530.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

Review 1.  Bacterial infection in chronic obstructive pulmonary disease.

Authors:  T F Murphy; S Sethi
Journal:  Am Rev Respir Dis       Date:  1992-10

2.  Bacteriology of middle ear fluid specimens obtained by tympanocentesis from 111 Colombian children with acute otitis media.

Authors:  H Trujillo; R Callejas; G I Mejía; L Castrillón
Journal:  Pediatr Infect Dis J       Date:  1989-06       Impact factor: 2.129

3.  Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway.

Authors:  Beinan Wang; David J Lim; Jiahuai Han; Young S Kim; Carol B Basbaum; Jian-Dong Li
Journal:  J Biol Chem       Date:  2001-11-06       Impact factor: 5.157

4.  Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells.

Authors:  Tae-Hee Lee; Hava Avraham; Seung-Hoon Lee; Shalom Avraham
Journal:  J Biol Chem       Date:  2002-01-09       Impact factor: 5.157

5.  Role of NF-kappaB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS cells.

Authors:  Sang Hui Chu; Hyeyoung Kim; Jeong Yeon Seo; Joo Weon Lim; Naofumi Mukaida; Kyung Hwan Kim
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

6.  Phosphatidylinositol 3-kinases in carcinoembryonic antigen-related cellular adhesion molecule-mediated internalization of Neisseria gonorrhoeae.

Authors:  James W Booth; David Telio; Edward H Liao; Shannon E McCaw; Tsuyoshi Matsuo; Sergio Grinstein; Scott D Gray-Owen
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

7.  Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1.

Authors:  Mark S Hipp; Carmen Urbich; Petra Mayer; Jörg Wischhusen; Michael Weller; Michael Kracht; Ioakim Spyridopoulos
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

8.  Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a).

Authors:  Jens Henrik Norum; Kent Hart; Finn Olav Levy
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

9.  Interleukin-8 expression in otitis media.

Authors:  K S Maxwell; J E Fitzgerald; J A Burleson; G Leonard; R Carpenter; D L Kreutzer
Journal:  Laryngoscope       Date:  1994-08       Impact factor: 3.325

10.  The Pseudomonas autoinducer N-(3-oxododecanoyl) homoserine lactone induces cyclooxygenase-2 and prostaglandin E2 production in human lung fibroblasts: implications for inflammation.

Authors:  Roger S Smith; Rodney Kelly; Barbara H Iglewski; Richard P Phipps
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  22 in total

1.  ERK2-dependent activation of c-Jun is required for nontypeable Haemophilus influenzae-induced CXCL2 upregulation in inner ear fibrocytes.

Authors:  Sejo Oh; Jeong-Im Woo; David J Lim; Sung K Moon
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

2.  Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces.

Authors:  Adam J Ratner; Elena S Lysenko; Marina N Paul; Jeffrey N Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

3.  Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.

Authors:  Cecilia L Chin; Lori J Manzel; Erin E Lehman; Alicia L Humlicek; Lei Shi; Timothy D Starner; Gerene M Denning; Timothy F Murphy; Sanjay Sethi; Dwight C Look
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

4.  Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae.

Authors:  Yoshiyuki Kyo; Kosuke Kato; Yong Sung Park; Sachin Gajghate; Sachin Gajhate; Tsuyoshi Umehara; Erik P Lillehoj; Harumi Suzaki; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02       Impact factor: 6.914

5.  Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Authors:  Charles S Berenson; Timothy F Murphy; Catherine T Wrona; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells.

Authors:  C K Wong; C B Wang; W K Ip; Y P Tian; C W K Lam
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

7.  Role of p38 mitogen-activated protein kinase in middle ear mucosa hyperplasia during bacterial otitis media.

Authors:  Sean D Palacios; Kwang Pak; Alexander Z Rivkin; Ayse G Kayali; Darrell Austen; Christoph Aletsee; Asa Melhus; Nicholas J G Webster; Allen F Ryan
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Regulation of bacteria-induced intercellular adhesion molecule-1 by CCAAT/enhancer binding proteins.

Authors:  Lori J Manzel; Cecilia L Chin; Mark A Behlke; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

9.  Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus.

Authors:  Catherine L Shelton; Forrest K Raffel; Wandy L Beatty; Sara M Johnson; Kevin M Mason
Journal:  PLoS Pathog       Date:  2011-11-03       Impact factor: 6.823

10.  Activation of epidermal growth factor receptor is required for NTHi-induced NF-κB-dependent inflammation.

Authors:  Xiangbin Xu; Rachel R Steere; Christine A Fedorchuk; Jinjiang Pang; Ji-Yun Lee; Jae Hyang Lim; Haidong Xu; Zhixing K Pan; Sanjay B Maggirwar; Jian-Dong Li
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.